SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000093751-23-000088
Filing Date
2023-02-02
Accepted
2023-02-02 12:29:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 Iovance_Biotherapeutics_Inc.txt SC 13G 8546
  Complete submission text file 0000093751-23-000088.txt   10696
Mailing Address ONE LINCOLN STREET BOSTON MA 02111
Business Address ONE LINCOLN STREET BOSTON MA 02111 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

IRS No.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 6022 State Commercial Banks

Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Subject) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85384 | Film No.: 23579681
SIC: 2836 Biological Products, (No Diagnostic Substances)